Health insurers are passing on the high cost of some meds to patients, asking them to pay up to one-third the price of expensive drugs; the policies affect drugs for such serious illnesses as cancer, multiple sclerosis, and rheumatoid arthritis, and they apply even to meds without cheaper equivalents. Report [1]
Links:
[1] http://www.nytimes.com/2008/04/14/us/14drug.html?ex=1365912000&en=1f1771e2213b87ba&ei=5124&partner=permalink&exprod=permalink